Beruflich Dokumente
Kultur Dokumente
Regular Article
MD,'
HIDEAKI NAKAYAMA,
MD'
AND
Abstract
We investigated the incidence of the following conditions: inflammatory neurological and neuromuscular
diseases, adult meningitis and adult encephalitis in Yonago City, and Guillain-Barre syndrome (GBS),
chronic inflammatory demyelinating polyradiculoneuropathy (CIDP), polymyositis/dermatomyositis (PM/
DM), periarteritis nodosa (PN) and HTLV-1 associated myelopathy (HAM) during the period 1988-1992 in
Tottori Prefecture, Japan. The annual incidence per 100 000 population was as follows: meningitis, 4.38;
encephalitis, 0.90; GBS, 1.14; PM/DM, 1.01;and PN, 0.32. The prevalence per 100 000 population CIDP,
0.81; PM/DM, 9.92; PN, 2.59; and HAM, 1.30. There was marked localization of HAM in western
Tottori, and there was seasonal variation in the prevalence of meningitis, encephalitis and GBS. The mean
age at onset of meningitis was lower than that for encephalitis. Comparison with reported data revealed
interracial differences in the epidemiology of PM/DM and PN.
Key words
INTRODUCTION
The inflammatory neurological and inflammatory neuromuscular diseases commonly seen at neurological hospitals
in Japan include meningitis, encephalitis, Guillain-Barre
syndrome (GBS), chronic inflammatory demyelinating
polyradiculoneuropathy (CIDP), polymyositis/dermatomyositis (PM/DM), periarteritis nodosa (PN) and HTLV-1
associated myelopathy (HAM). However, there are only a
few reports regarding the epidemiology of these conditions
We therefore carried out an epidemiological
in
study of the incidence of these seven inflammatory neurological and inflammatory neuromuscular diseases in Tottori
Prefecture,Japan, during the 5 year period 1988-1992. The
aims of this study were to clarify the epidemiology of these
diseases in a representative area of Japan and to compare the
prevalence of these diseases in Japan with that in other
various countries.
condition^.^.^
M. Kusumi et
170
a/.
r-
x
City
Toltori C i t t h
Kurayoshi City
RESULTS
Meningitis
During the period 1988-1992,29 patients (16 males and 13
females) were diagnosed as having meningitis in Yonago
Table 1. Distribution of the onset of meningitis and encephalitis during the period 1988 to 1992 in Yonago City
Meningitis
Year
Population
No. patients
Encephalitis
Incidence per
100 000 per year
Incidence per
No. patients
1988
131 773
1.52
0.00
1989
132 078
4.54
1.51
1990
132 361
6
4
3.02
1.51
1991
132 598
11
8.30
0.00
1992
132 957
4.51
1.50
171
(Fig. 5). The peak age at onset was 20-29 years in males and
60-69 years in females (Fig. 6). The mean age at onset was
46.3 20.37 years (male, 37.7 k 19.93; female, 52.7 -t
18.70). The preceding symptoms, such as upper respiratory
infections, were seen in 51.4% of the cases. There was no
geographical localization of the incidence within the Prefecture.
Jan Feb Mar Apr May Jun
Polymyositis/dermatomyositis
15-
21-
31-
51-
41-
61-
71-
Age (years)
Figure 3. Age at onset of meningitis. (m) male; (0)female.
8
7
Encephalitis
During the same period (1988-1992), six patients (three
males and three females) wree diagnosed as having encephalitis in Yonago City. The average yearly incidence of
encephalitis was 0.90 +- 0.83 per 100 000 population. In
most of the encephalitis cases, the onset was in the Autumn
or Winter (Fig. 4). The mean age at onset was 59.2 f8.86
years (male, 61.3 f9.00; female, 57.0 j, 10.1).The origin of
encephalitis was HSV Type 1 in four of the patients.
=
5
a,
.-
z 4
a
z 2
1
0
Jan Feb Mar Apr May Jun
Nov Df?C
Guillain-Barre syndrome
During the same period (1988-1992), 35 patients (15 males
and 20 females) were diagnosed as having GBS in Tottori
Prefecture. The average yearly incidence of GBS was
1.1420.12 per 100 000 population (Table 2). The yearly
incidence ranged from 0.97 in 1989, to 1.30 in 1990. In
most cases of GBS, the onset was in early Spring or Winter
n
m 2 /
0-4
10-
20-
30-
40-
50-
60-
70-
Age (years)
n
"
Jan Feb Mar
M. Kusumi et al.
172
Table 2. Distribution of the onset of Guillain-Barre syndrome (GBS), polymyositis/dematomyositis (PM/DM) and periarteritis nodosa (PN) during
the period 1988-1992 in Tottori Prefecture
GBS
PM/DM
Incidence per
PN
Incidence per
Incidence per
No. patients
No. patients
1.13
0.97
1.30
1.14
1.14
5
6
12
3
5
0.81
0.97
1.95
0.49
0.81
6
8
7
0.00
0.32
0.81
0.32
0.16
Year
Population
No. patients
1988
618 000
1989
1990
1991
1992
618 000
615 741
616 000
614 410
2
5
2
1
Table 3. Number of patients diagnosed with prevalence of chronic inflammatory demyelinating polyradiculoneuropathy (CIDP), polymyositis/
dermatomyositis (PM/DM), periarteritis nodosa (PN), HTLV-1 associated myelopathy (HAM) (Tottori Prefecture)
Disease
No.
male
Prevalence per
100 000 population
No.
female
Prevalence per
100 000 population
Total
Prevalence per
100 000 population
CIDP
PM/DM
PN
HA
4
17
8
3
1.36
5.76
2.71
1.01
1
44
8
5
0.31
13.71
2.49
1.56
5
61
16
8
0.81
9.92
2.59
1.30
Periarteritis nodosa
m V - 1 associated myelopathy
5 r
0-
10-
20-
30-
40-
SO-
60-
73-
0-
Age (years)
Figure 7. Age at onset of polymyositis/dermatomyosis. (m) male;
(qfemale.
11-
21-
31-
41-
Age (years)
Figure 8.
51-
61-
71-
DISCUSSION
The incidence and prevalence of meningitis and encephalitis
are high in children, but not in adults. Therefore in Japan,
there are many epidemiological reports of these diseases in
children, but few in adults.2 Beghi reported that the incidence of meningitis and encephalitis in Olmsted County in
individuals over the age of 10 years was 1.4-15.8 and
1.8-6.3, respectively,per 100 000 population per year;" the
same rates in our study was 4.38k2.52 and 0.90k0.83,
respectively. In adults, the incidence of meningitis and
encephalitis in Japan is similar to that in other countries.
The incidence of GBS in different areas of the world
ranges from 0.4 to 2.2 per 100 000 population per ear,'^-'^
and the 1.14 incidence in Tottori Prefecture is within this
range.
The prevalence of PM/DM found in our study were
higher than those reported for Kumamoto City and Kumamoto Prefecture.' The methodology used in the Kumamoto study, in contrast to our methodology, may have
excluded data from some of the hospitals in the area, and the
results of that study thus may not mirror the actual prevalence in Kumamoto. Medsger reported that the incidence of
polymyositis was 0.12-0.84 per 100 000 population per
year, and that the incidence in black people was higher than
that in white pe0p1e.l~Our data indicate that the incidence
in Japanese is higher than that in white people and similar to
that in black people.
Epidemiological reports regarding PN in Japan or elsewhere are rare. In Rochester, USA, the reported incidence is
0.7 to 1.8 per 100 000 population per year and the prevalence 6.3 per 100 000 population.16 This suggests that these
values are slightly higher than those in Japan. Our study
revealed higher incidence of PN than that reported in an
epidemiological study of P N in Japan." This discrepancy is
due to differences in methodology; in the latter study the
incidence was extrapolated based on the written applications
for medical aid for specific incurable diseases.
We observed a marked geographical localization of HAM
in western Tottori Prefecture. The prevalence of HAM
among HTLV-1 carriers in Japan aged 20 to 69 years is 65.7
per 100 000 population for males and 86.9 per 100 000 for
1-/3
ACKNOWLEDGMENTS
The authors wish to thank the medical doctors in Totton
Prefecture, Mrs Tanaka, Division of Health Promotion and
Disease Control, Deputation of Welfare and Health, Tottori
Prefectural Office and Dr Oshiro, Department of Public
Health, Faculty of Medicine, Tottori University for having
made this work possible.
This study was supported in part by a Grant for Nervous
and Mental Disorders (No. 3A-3), from the National Center
of Neurology and Psychiatry, the Ministry of Health and
Welfare, Japan.
REFERENCES
1. Araki S, Uchino M, Kumamoto T. Prevalence studies of multiple
sclerosis, myasthenia gravis, and myopathies in Kumamoto district, Japan.
2. Fukuyama Y.Classificationand epidemiologyof meningitis. Clin.
Neurosci. 1986; 9: 19-23 (in Japanese).
3. Osame M, Nishitani H, Kubota H, Igata A. The second nationwide survey of HTLV-1 associated myelopathy in Japan and the
report of WHO-HAM/TSP international meeting. In:Nishitani
M. Kusumi et al.
174
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
H ed. The report ofthe Neuroimmunological Disorders Research Committee. Nakanishi Press, Tokyo. 1988; 245-249.
Shibasaki H, Tokudome S, Kuroda Y, Yamagawa T, Yoshihara M.
Prevalence of HTLV-1-associated myelopathy among HTLV-1
carriers in Saga, Japan. Neuroepidemiology 1989; 8: 124-127.
Harada H, Nishikawa S, Takahashi K. Epidemiology of Parkinsons disease in a Japanese city. Arch. Neurol. 1983; 40: 151-154.
Urakami K, Igo M, Takahashi K. An epidemiologic study of
cerebrovascular diseases in western Japan: With special reference
to transient ischemic attack. Stroke 1987; 18: 396-401.
National Institute of Neurological and Communications Disorders and Stroke Ad Hoc Committee. Criteria for diagnosis of
Guillain-Barre syndrome. Ann. Neurol. 1 9 7 8 3: 565-566.
AdHoc Subcommittee of the American Academy of Neurology.
Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP). Neurology 1991; 41: 617-618.
Bohan A, Peter JB. Polymyositis and dermatomyositis N . Engl. .]
Med. 1975; 292: 344-347.
Lightfoot RW, Michel BA, Bloch DA et a/. The American
College of Rheumatology 1990 criteria for the classification of
polyarteritis nodosa. Arthritis Rheum. 1 9 9 0 33: 1088-1093.
Beghi E, Nicolosi A, Kurland LT, Mulder DW, Hauser WA,
Shuster L. Encephalitis and aseptic meningitis, Olmsted County,
Minnesota, 1950-1981: I. Epidemiology. Ann. Neurol. 1984; 16:
283-294.
Alter M. The epidemiology of Guillain-Barrt syndrome. Ann.
Neurol. 1990; 27 (Suppl): S7-12.
Matias-Guitu J, Martin R, Blanquer J et a / . Incidence of Guillain-
14.
15.
16.
19.
20.
21.
Barre syndrome and ganglioside intake in Alcoi, Spain. Neuroepidemiology 1993; 12: 58-60.
Sedano MJ, Calleja J, Canga E, Berciano J. Guillain-Barre syndrome in Cantabria, Spain. An epidemiological and clinical study.
Acta Neurol. Scand. 1994; 89: 287-292.
Medsger TA, Dawson W N , Masi AT. The epidemiology of
polymyositis. A m . ] . Med. 1970; 48: 715-723.
Kurland LT, Chuang TY, Hunder GG. The epidemiology of
systemic arteritis. In: Laurence RC, Shulman LE (Eds). Current
Topics in Rheumatology - Epidemiology of the Rheumatic diseases.
Gower, New York. 1984; 196-205.
Minowa M, Aizawa S, On0 Y, Nagai M, Yanagawa H. A
comparison of descriptive epidemiology in intractable diseases
based on different sources of dad: amyloidosis and polyarteritis
nodosa.]. Health Welfre Stat. 1992; 39: 14-17 (in Japanese).
Yamaguchi K. Human T-lymphotrophic virus type 1 in Japan.
Lancet 1994; 343: 213-216.
Yamashita K, Miyamura K, Yamadera S et a / . Enteroviral aseptic
meningitis in Japan, 1981-1991; A report of the National
Epidemiological Surveillanceof Infectious Agents in Japan.]pn].
Med. Sci. Biol. 1992; 45: 151-161.
Kuroki S, Saida T, Nukina M et a/. Campylobacter jejuni strains
from patients with Guillain-Barre syndrome belong mostly to
Penner serogroup 19 and contain b-N-acetylglucosamine residues. Ann. Neurol. 1993; 33: 243-247.
SigurgeirssonB, Lindelof B, Edhag 0, Allander E. Risk of cancer
in patients with dermatomyosis or polymyositis, a population
study. N . Engl. J. Med. 1992; 326: 363-367.